CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Vascular Disease News Wire
Cilostazol May Be Better Than Aspirin in Preventing Recurrent Strokes
The antiplatelet drug cilostazol — used in the United States to treat leg pain associated with peripheral vascular disease — was more effective and safer than aspirin at preventing recurrent strokes in a Japanese trial presented as late-breaking science at the American Stroke Association's International Stroke Conference 2010.
“This study demonstrated for the first time that cilostazol significantly reduces the risk of recurrent ischemic stroke and the incidence of serious cerebral hemorrhage, compared to aspirin,” said Yukito Shinohara, MD, lead author of the study and head of neur
ICSS Interim Results Show CEA Safer than CAS in Symptomatic Patients
The International Carotid Stenting Study (ICSS) investigators presented their interim analysis of the safety of carotid artery stenting versus endarterectomy in symptomatic patients in the February 26th early online publication of The Lancet. This multicenter randomized, controlled trial enrolled 1,713 patients (855 in the stenting arm; 858 in the endarterectomy arm). The primary outcome is fatal or disabling stroke in any territory at 3 years, which has yet to be analyzed. The interim safety analysis by intention-to-treat involved the 120-day rate of stroke, death, or procedural myocardial in
CREST Trial Results Announced at 2010 International Stroke Conference
Endarterectomy and Stenting Are Similar in Safety and Efficacy, But Show Differences in Stroke, Heart Attack and Death Rates at Certain Ages
SAN ANTONIO, Feb. 26, 2010 — Carotid endarterectomy and carotid stenting proved similar in overall long-term safety and efficacy, but showed differences in stroke and heart attack in the weeks following the procedure, according to late-breaking science presented at the American Stroke Association’s International Stroke Conference 2010.
The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST), funded by the National Ins
Vascular Solutions Launches the Vari-Lase® 15 Watt Endovenous Laser Console
Vascular Solutions, Inc. (Minneapolis, Minnesota) announces the availability of the Vari-Lase® 15 Watt Endovenous Laser Console for the treatment of varicose veins. The new Vari-Lase console incorporates several technological innovations, including 60% less weight, 50% smaller footprint and brighter display screen over the original 30 Watt Vari-Lase console, but retains the open architecture SMA-905 fiber connector that allows the physician to choose their supplier of laser fibers.
Several new features were added to the Vari-Lase 15 Watt console to advance the endovenous laser procedure
Statins Fail to Slow Progression of Small AAAs
The prescription of statin therapy does not slow the expansion of abdominal aortic aneurysms (AAA), according to the results of new study.[1] Similarly, there was no association with AAA expansion and LDL- and total-cholesterol levels, report investigators.
The negative results, according to lead author Dr. Craig Ferguson (James Cook University, Queensland, Australia), highlight the "need for ongoing preclinical studies and randomized trials designed to develop medication targeted specifically at reducing AAA growth."
Publishing the findings in the February 2010 issue of the American Hea
EVAR Better Than Open Surgery for Repair of Ruptured AAAs in EVAR-Suitable Patients
At ISET 2010, which took place in Hollywood, Florida, a Dutch study was presented by investigator Dr. Jan Ten Bosch of Atrium Medical Center in The Netherlands (Ten Bosch J. Endovascular repair versus open surgery in EVAR-suitable patients with a ruptured AAA. ISET 2010: 22nd Annual International Symposium on Endovascular Therapy; January 18, 2010; Hollywood, Florida).
The study showed a > 25% reduction in mortality in patients who underwent EVAR compared to those who underwent an open surgical approach to repair their ruptured AAA. Of note, all patients included in the study were suitable
Vascular Solutions Launches Gator™ ClipSeal Plug
Vascular Solutions, Inc. (Minneapolis, Minnesota) announces the availability of the new Gator™ ClipSeal Plug designed to maintain a hemostatic seal around 0.035 inch or 0.038 inch guidewires within large hemostatic valve introducer sheaths to minimize blood loss. The Gator is intended for use with commonly used 12 Fr to 24 Fr introducer sheaths in procedures such as Endovascular Aneurysm Repair (EVAR) to treat abdominal aortic aneurysms (AAA) or thoracic aortic aneurysms (TAA).
The unique design of the Gator provides an easy and effective solution for minimizing blood loss
Abbott's XIENCE V® Approved in Japan
Second Largest Drug Eluting Stent Market Worldwide Launch in Japan to Begin Immediately Following Final Reimbursement Authorization
Abbott (Abbott Park, Illinois) announced in January that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its XIENCE V® Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. Japan is the second largest drug-eluting stent market in the world after the United States, with approximately 200,000 stent procedures performed each year. The company plans to launch XIENCE V in Japan in the
Medtronic Receives FDA Approval for Melody® Transcatheter Pulmonary Valve
Medtronic, Inc. (Minneapolis, Minnesota) announced that its Melody® Transcatheter Pulmonary Valve has received U.S. FDA approval under a Humanitarian Device Exemption (HDE).
The Melody valve will benefit children and adults who are born with a malformation of their pulmonary valve. These patients often require open-heart surgery to restore effective blood flow to their lungs. Previously, the only way to repair or replace a failed pulmonary valve conduit was through additional surgeries. To date, more than 1,100 patients worldwide have received a Melody valve.
“The Melody Transcatheter P
Medtronic Receives FDA Approval for Melody® Transcatheter Pulmonary Valve
Medtronic, Inc. (Minneapolis, Minnesota) announced that its Melody® Transcatheter Pulmonary Valve has received U.S. FDA approval under a Humanitarian Device Exemption (HDE).
The Melody valve will benefit children and adults who are born with a malformation of their pulmonary valve. These patients often require open-heart surgery to restore effective blood flow to their lungs. Previously, the only way to repair or replace a failed pulmonary valve conduit was through additional surgeries. To date, more than 1,100 patients worldwide have received a Melody valve.
“The Melody Transc
Vascular Disease Blogs
VDM Monthly Poll
Digital Supplements
Terumo Clinical Case Update This clinical case update was supported through an unrestricted educational grant from Terumo Medical Corporation.
Vascular Disease News Wire
- Monday, March 1, 2010 - 22:25
- Sunday, February 28, 2010 - 20:53
- Friday, February 26, 2010 - 10:50
Anytown, California
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.
